Histamine receptor 2 is a key influence in immune responses to intestinal histamine- secreting microbes  Ruth Ferstl, PhD, Remo Frei, PhD, Elisa Schiavi,

Slides:



Advertisements
Similar presentations
Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
Advertisements

Vitamin D3 treatment of vitamin D–insufficient asthmatic patients does not alter immune cell function  Brandy Reid, MS, Pierre-Olivier Girodet, MD, PhD,
Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4–mediated suppression of IL-10  Susanne Kaesler, PhD, Thomas Volz, MD, Yuliya.
Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo  Jan Gutermuth, MD, Mayte Bewersdorff,
Dorothea Dijkstra, MSc, Rob Leurs, PhD, Paul Chazot, PhD, Fiona C
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2  Natalija Novak, MD, Nihal Mete, MD, Caroline.
Histamine receptor 2 modifies dendritic cell responses to microbial ligands  Remo Frei, PhD, Ruth Ferstl, PhD, Patrycja Konieczna, MSc, Mario Ziegler,
CD39: A new surface marker of mouse regulatory γδ T cells
Volume 140, Issue 1, Pages e2 (January 2011)
Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
Sytze de Roock, PhD, Arie J
IL-25 and CD4+ TH2 cells enhance type 2 innate lymphoid cell–derived IL-13 production, which promotes IgE-mediated experimental food allergy  Jee-Boong.
Allergy prevention starts before conception: Maternofetal transfer of tolerance protects against the development of asthma  Tobias Polte, PhD, Christian.
Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes  Naoko Kanda, MD, PhD, Hiroshi Mitsui, MD, PhD, Shinichi.
Ting-ting Zhang, MSc, Klaus Okkenhaug, PhD, Baher F
Innate IL-13–producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity  Jillian L. Barlow, PhD, Agustin Bellosi,
Histamine H2 receptor stimulation upregulates TH2 chemokine CCL17 production in human M2a macrophages  Susanne Mommert, PhD, Karl Gregor, MD, Kristine.
T-cell regulation during viral and nonviral asthma exacerbations
Penicillium marneffei infection and impaired IFN-γ immunity in humans with autosomal- dominant gain-of-phosphorylation STAT1 mutations  Pamela P.W. Lee,
Regulation of TH17 cells in the mucosal surfaces
Targeting Toll-like receptors on dendritic cells modifies the TH2 response to peanut allergens in vitro  Pierre Pochard, PhD, Brian Vickery, MD, M. Cecilia.
Restoration of T-box–containing protein expressed in T cells protects against allergen- induced asthma  Jung Won Park, MD, Hyun Jung Min, MS, Jung Ho Sohn,
Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: Role of macrophage scavenger receptor class A type I and II 
IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis  Stéphanie.
Brecht Steelant, PhD, Sven F
Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-γ/IL-17 balance in T cell–mediated skin inflammation  Béatrice Vanbervliet,
Glucocorticoids promote intrinsic human TH17 differentiation
Histamine in the immune regulation of allergic inflammation
Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps  Can Altunbulakli, MSc, Rita Costa,
Vitamin D3 treatment of vitamin D–insufficient asthmatic patients does not alter immune cell function  Brandy Reid, MS, Pierre-Olivier Girodet, MD, PhD,
Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3–positive regulatory versus TH2 effector cells to.
Clemastine causes immune suppression through inhibition of extracellular signal- regulated kinase–dependent proinflammatory cytokines  Pål Johansen, PhD,
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen- presenting cells that induce proallergic T cells  Susanne Ebner, PhD,
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Immune modulation by neuronal electric shock waves
TH17 and TH22 cells: A confusion of antimicrobial response with tissue inflammation versus protection  Mübeccel Akdis, MD, PhD, Oscar Palomares, PhD,
Regulation of allergic airway inflammation by class I–restricted allergen presentation and CD8 T-cell infiltration  James W. Wells, PhD, Christopher J.
Targeting allergen to FcγRI reveals a novel TH2 regulatory pathway linked to thymic stromal lymphopoietin receptor  Kathryn E. Hulse, PhD, Amanda J. Reefer,
Human TH2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1  Celine N. Parmentier, MSc, Elisabeth.
Fibronectin is a TH1-specific molecule in human subjects
A novel allergen-specific therapy with CD40-silenced B cells and dendritic cells  Motohiko Suzuki, MD, PhD, Makoto Yokota, MD, PhD, Yoshihisa Nakamura,
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
Sarita Sehra, PhD, Weiguo Yao, PhD, Evelyn T. Nguyen, MS, Nicole L
Fibronectin is a TH1-specific molecule in human subjects
T-bet inhibits innate lymphoid cell–mediated eosinophilic airway inflammation by suppressing IL-9 production  Ayako Matsuki, MD, Hiroaki Takatori, MD,
Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)  Kornvalee Meesilpavikkai,
Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice  Fu-Gang Zhu, PhD, Ekambar R. Kandimalla,
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis  Margarete Niebuhr, MD, Helena Scharonow, MS, Merle Gathmann,
Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T H1 subsets  Martin Willheim,
Sabah El-Ghaiesh, MSc, Joseph P
In vivo maturation of TH cells in relation to atopy
Staphylococcal enterotoxin A–activated regulatory T cells promote allergen-specific TH2 response to intratracheal allergen inoculation  Wei-ping Zeng,
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
Enhanced CD46-induced regulatory T cells suppress allergic inflammation after Dermatophagoides pteronyssinus–specific immunotherapy  Yi-Giien Tsai, MD,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
Duy Pham, PhD, Sarita Sehra, PhD, Xin Sun, PhD, Mark H. Kaplan, PhD 
The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis  Meiqin Wang, MD, PhD, Julita Ramirez, DVM, PhD,
Antigen coupled with Lewis-x trisaccharides elicits potent immune responses in mice  Shih-Chang Hsu, BS, Tsung-Hsien Tsai, MD, Hirokazu Kawasaki, PhD,
Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy  Ulrich R. Müller, MD, Marek Jutel, MD,
IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation  Kentaro Takahashi, MD, Koichi.
IL-10–producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients  Antje Prasse, MD, Martin Germann,
Human basophils may not undergo modulation by DC-SIGN and mannose receptor– targeting immunotherapies due to absence of receptors  Mrinmoy Das, MSc, Caroline.
Eric B. Brandt, PhD, Melissa K. Mingler, MS, Michelle D
Ovalbumin-specific IgE modulates ovalbumin-specific T-cell response after repetitive oral antigen administration  Nemuko Omata, MD, Yusei Ohshima, MD,
Julie Negri, BA, S. Brandon Early, BA, John W
Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production  Monika Majewska-Szczepanik, PhD,
Presentation transcript:

Histamine receptor 2 is a key influence in immune responses to intestinal histamine- secreting microbes  Ruth Ferstl, PhD, Remo Frei, PhD, Elisa Schiavi, PhD, Patrycja Konieczna, PhD, Weronika Barcik, MSc, Mario Ziegler, Dipl-Ing, Roger P. Lauener, MD, Christophe Chassard, PhD, Christophe Lacroix, PhD, Cezmi A. Akdis, MD, Liam O'Mahony, PhD  Journal of Allergy and Clinical Immunology  Volume 134, Issue 3, Pages 744-746.e3 (September 2014) DOI: 10.1016/j.jaci.2014.04.034 Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Histamine from Lactobacillus saerimneri 30a is biologically active. A, L saerimneri 30a culture supernatants significantly reduced LPS-induced NF-κB activation, which was attenuated by blocking the H2R with famotidine. Supernatant from Lactobacillus reuteri (which does not secrete histamine) increased LPS-induced NF-κB activation. *P < .05 compared with LPS alone. Results are expressed as mean ± SD for 3 separate experiments. B, HPLC analysis revealed high levels of histamine and cadaverine in supernatants from L saerimneri 30a cultures. Journal of Allergy and Clinical Immunology 2014 134, 744-746.e3DOI: (10.1016/j.jaci.2014.04.034) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Lactobacillus saerimneri 30a modulates mucosal immune responses via the H2R. Mice (n = 6 per group) received L saerimneri 30a daily for 6 days by oral gavage (1 × 109 cfu/mL). Animals exhibited significant weight loss (A) associated with signs of deteriorating health (B), which was significantly worse in the H2R-deficient animals than in wild-type controls at day 6 (*P < .05 between groups). C, In vitro cytokine secretion from resected PPs was measured after PMA and ionomycin stimulation. L saerimneri 30a administration was associated with the suppression of IL-17 and IFN-γ secretion in wild-type mice. In contrast, IL-4, IL-6, and IL-17 secretion was significantly increased in H2R-deficient animals (*P < .05; **P < .01). PMA, Phorbol 12-myristate 13-acetate. Journal of Allergy and Clinical Immunology 2014 134, 744-746.e3DOI: (10.1016/j.jaci.2014.04.034) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 The H2R antagonist famotidine enhances the detrimental effects of L saerimneri 30a. Mice (n = 8 per group) received L saerimneri 30a daily for 6 days by oral gavage (1 × 109 cfu/mL). Animals exhibited significant weight loss (A) associated with signs of deteriorating health (B), which was significantly worse in the famotidine-treated animals than in controls (*P < .05 between groups). C, In vitro cytokine secretion from mucosal cells was measured after PMA and ionomycin stimulation. L saerimneri 30a administration was associated with the suppression of IL-17; however, the secretion of IL-17 was enhanced in famotidine-treated animals. PMA, Phorbol 12-myristate 13-acetate. Journal of Allergy and Clinical Immunology 2014 134, 744-746.e3DOI: (10.1016/j.jaci.2014.04.034) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 CD4+ lymphocyte cytokine response to L saerimneri 30a. Intracellular staining of IL-17+ and IFN-γ+ CD4 lymphocytes was performed for PP (A) and mesenteric lymph nodes (B). The percentage of IL-17+ lymphocytes within the PP decreased after the administration of L saerimneri to both wild-type and H2R-deficient animals, while no significant differences were observed in the mesenteric lymph nodes. A nonstatistically significant trend toward reduced IFN-γ+ lymphocytes after the administration of L saerimneri 30a was observed only in PP cells isolated from wild-type animals (n = 6 per group, *P < .05). Journal of Allergy and Clinical Immunology 2014 134, 744-746.e3DOI: (10.1016/j.jaci.2014.04.034) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions